Conning Inc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $425K | Sell |
6,778
-1,128
| -14% | -$90.2K | 0.01% | 221 |
|
|
2025
Q4 | $754K | Sell |
7,906
-1,224
| -13% | -$120K | 0.03% | 199 |
|
|
2025
Q3 | $891K | Hold |
9,130
| – | – | 0.03% | 193 |
|
|
2025
Q2 | $981K | Sell |
9,130
-254
| -3% | -$25.7K | 0.03% | 182 |
|
|
2025
Q1 | $947K | Buy |
9,384
+9
| +0.1% | +$906 | 0.03% | 183 |
|
|
2024
Q4 | $837K | Sell |
9,375
-1,273
| -12% | -$112K | 0.03% | 187 |
|
|
2024
Q3 | $892K | Sell |
10,648
-111
| -1% | -$8.75K | 0.03% | 186 |
|
|
2024
Q2 | $829K | Buy |
10,759
+412
| +4% | +$30.2K | 0.03% | 186 |
|
|
2024
Q1 | $709K | Sell |
10,347
-240
| -2% | -$15.4K | 0.02% | 202 |
|
|
2023
Q4 | $612K | Buy |
10,587
+65
| +0.6% | +$3.47K | 0.02% | 202 |
|
|
2023
Q3 | $556K | Sell |
10,522
-140
| -1% | -$7.34K | 0.02% | 199 |
|
|
2023
Q2 | $577K | Sell |
10,662
-1,500
| -12% | -$78.3K | 0.02% | 207 |
|
|
2023
Q1 | $608K | Sell |
12,162
-69
| -0.6% | -$3.25K | 0.02% | 209 |
|
|
2022
Q4 | $566K | Sell |
12,231
-27
| -0.2% | -$1.17K | 0.02% | 228 |
|
|
2022
Q3 | $475K | Sell |
12,258
-2,893
| -19% | -$116K | 0.02% | 231 |
|
|
2022
Q2 | $565K | Sell |
15,151
-114
| -0.7% | -$4.64K | 0.02% | 229 |
|
|
2022
Q1 | $676K | Buy |
15,265
+380
| +3% | +$16.5K | 0.02% | 223 |
|
|
2021
Q4 | $632K | Buy |
14,885
+1,835
| +14% | +$77.1K | 0.02% | 222 |
|
|
2021
Q3 | $566K | Sell |
13,050
-4,299
| -25% | -$190K | 0.02% | 247 |
|
|
2021
Q2 | $742K | Sell |
17,349
-1,682
| -9% | -$70.8K | 0.02% | 222 |
|
|
2021
Q1 | $736K | Sell |
19,031
-1,710
| -8% | -$64.7K | 0.02% | 223 |
|
|
2020
Q4 | $746K | Sell |
20,741
-419
| -2% | -$15.1K | 0.02% | 226 |
|
|
2020
Q3 | $809K | Buy |
21,160
+390
| +2% | +$15K | 0.03% | 213 |
|
|
2020
Q2 | $729K | Buy |
20,770
+1,258
| +6% | +$45.3K | 0.03% | 218 |
|
|
2020
Q1 | $637K | Sell |
19,512
-527
| -3% | -$20.6K | 0.03% | 221 |
|
|
2019
Q4 | $906K | Sell |
20,039
-800
| -4% | -$33.5K | 0.03% | 216 |
|
|
2019
Q3 | $848K | Sell |
20,839
-2,449
| -11% | -$104K | 0.03% | 233 |
|
|
2019
Q2 | $1M | Sell |
23,288
-3,530
| -13% | -$136K | 0.03% | 217 |
|
|
2019
Q1 | $1.03M | Buy |
26,818
+130
| +0.5% | +$4.96K | 0.03% | 242 |
|
|
2018
Q4 | $943K | Sell |
26,688
-2,760
| -9% | -$100K | 0.03% | 238 |
|
|
2018
Q3 | $1.13M | Sell |
29,448
-1,813
| -6% | -$63.3K | 0.03% | 253 |
|
|
2018
Q2 | $1.02M | Sell |
31,261
-1,120
| -3% | -$33.8K | 0.03% | 283 |
|
|
2018
Q1 | $885K | Buy |
32,381
+30
| +0.1% | +$815 | 0.03% | 288 |
|
|
2017
Q4 | $802K | Sell |
32,351
-760
| -2% | -$21K | 0.03% | 314 |
|
|
2017
Q3 | $966K | Sell |
33,111
-150
| -0.5% | -$4.14K | 0.03% | 276 |
|
|
2017
Q2 | $922K | Sell |
33,261
-260
| -0.8% | -$6.9K | 0.03% | 288 |
|
|
2017
Q1 | $834K | Sell |
33,521
-330
| -1% | -$8.02K | 0.03% | 298 |
|
|
2016
Q4 | $732K | Buy |
33,851
+420
| +1% | +$9.16K | 0.03% | 316 |
|
|
2016
Q3 | $796K | Buy |
33,431
+849
| +3% | +$20.3K | 0.03% | 297 |
|
|
2016
Q2 | $761K | Buy |
32,582
+480
| +1% | +$10.4K | 0.03% | 300 |
|
|
2016
Q1 | $604K | Buy |
32,102
+470
| +1% | +$8.26K | 0.03% | 319 |
|
|
2015
Q4 | $583K | Sell |
31,632
-1,630
| -5% | -$29.2K | 0.02% | 341 |
|
|
2015
Q3 | $546K | Sell |
33,262
-3,500
| -10% | -$59.8K | 0.02% | 333 |
|
|
2015
Q2 | $651K | Sell |
36,762
-340
| -0.9% | -$6.08K | 0.03% | 332 |
|
|
2015
Q1 | $659K | Sell |
37,102
-90
| -0.2% | -$1.42K | 0.03% | 334 |
|
|
2014
Q4 | $493K | Sell |
37,192
-1,110
| -3% | -$14.2K | 0.02% | 390 |
|
|
2014
Q3 | $452K | Sell |
38,302
-1,520
| -4% | -$19.1K | 0.02% | 393 |
|
|
2014
Q2 | $509K | Sell |
39,822
-2,370
| -6% | -$30.8K | 0.03% | 356 |
|
|
2014
Q1 | $570K | Buy |
42,192
+1,870
| +5% | +$24.5K | 0.03% | 338 |
|
|
2013
Q4 | $485K | Buy |
40,322
+6,920
| +21% | +$81.8K | 0.03% | 338 |
|
|
2013
Q3 | $392K | Buy |
33,402
+570
| +2% | +$6.17K | 0.03% | 331 |
|
|
2013
Q2 | $304K | Buy |
+32,832
| New | +$278K | 0.03% | 379 |
|
Other funds holding BSX
VCM
VPM
Conning Inc's BSX Position: Q1 2026 in Review
Conning Inc reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $90.2K and leaving 6,778 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #221.
Conning Inc first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.13M in Q3 2018. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Conning Inc held 6,778 shares of Boston Scientific worth $425K as of Q1 2026.
- Conning Inc sold 1,128 Boston Scientific shares in Q1 2026, an estimated $90.2K.
- Boston Scientific made up 0.01% of Conning Inc's portfolio in Q1 2026, its #221 holding.
- Conning Inc first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Conning Inc's Boston Scientific position peaked at $1.13M in Q3 2018.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.